IMAX (NYSE:IMAX) Reaches New 1-Year High on Strong Earnings

IMAX Corporation (NYSE:IMAX) shares hit a new 52-week high during trading on Friday after the company announced better than expected quarterly earnings. The stock traded as high as $45.76 and last traded at $44.5540, with a volume of 171194 shares traded. The stock had previously closed at $43.96.

The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.13. The firm had revenue of $102.84 million for the quarter, compared to analysts’ expectations of $96.09 million. IMAX had a return on equity of 15.65% and a net margin of 9.84%.The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period last year, the business posted $0.26 earnings per share.

Key Headlines Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
• Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
• Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
• Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
• Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion

Analyst Upgrades and Downgrades

IMAX has been the topic of a number of recent research reports. Keefe, Bruyette & Woods restated a “market perform” rating and issued a $60.00 price target on shares of IMAX in a research report on Friday, May 22nd. The Goldman Sachs Group reiterated a “neutral” rating and set a $42.00 price objective on shares of IMAX in a research note on Thursday. Benchmark reissued a “buy” rating on shares of IMAX in a report on Monday, June 22nd. Wells Fargo & Company lifted their target price on IMAX from $41.00 to $45.00 and gave the company an “equal weight” rating in a research note on Friday. Finally, Wall Street Zen raised IMAX from a “hold” rating to a “buy” rating in a report on Saturday. Ten research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $50.36.

Insider Buying and Selling at IMAX

In related news, CEO Richard L. Gelfond sold 8,943 shares of IMAX stock in a transaction dated Monday, April 27th. The shares were sold at an average price of $37.33, for a total value of $333,842.19. Following the sale, the chief executive officer directly owned 765,002 shares in the company, valued at $28,557,524.66. This trade represents a 1.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 20.55% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On IMAX

Hedge funds have recently made changes to their positions in the business. Orbis Allan Gray Ltd increased its position in IMAX by 31.7% in the 2nd quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after acquiring an additional 1,230,267 shares during the period. Westfield Capital Management Co. LP raised its stake in shares of IMAX by 44.6% during the fourth quarter. Westfield Capital Management Co. LP now owns 2,346,486 shares of the company’s stock valued at $86,726,000 after purchasing an additional 723,861 shares in the last quarter. Marsico Capital Management LLC acquired a new stake in IMAX in the fourth quarter worth about $18,149,000. Balyasny Asset Management L.P. bought a new position in IMAX in the 2nd quarter valued at about $12,568,000. Finally, Nuveen LLC grew its position in IMAX by 253.0% in the 4th quarter. Nuveen LLC now owns 507,377 shares of the company’s stock valued at $18,753,000 after buying an additional 363,658 shares in the last quarter. Institutional investors own 93.51% of the company’s stock.

IMAX Stock Performance

The stock has a market cap of $2.38 billion, a price-to-earnings ratio of 60.02, a PEG ratio of 1.59 and a beta of 0.37. The company’s 50 day simple moving average is $39.99 and its 200 day simple moving average is $38.03.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.